A Large Proportion of Medical Students Experience Migraines, Choose to Self-Manage Symptoms
September 1st 2022Though around 42% of medical students in study experience headaches, many of these causing significant functional disability, most choose to self-manage symptoms with sleep and medication.
Read More
Effective Treatment for Some Patients with Arndt-Gottron Syndrome Can Be Achieved With IVIG
September 1st 2022Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.
Read More
Study: Climate Hazards Aggravate More than Half of Human Diseases Caused by Pathogens
August 25th 2022Climatic hazards were implicated for enhancing specific aspects of pathogens, increasing capacity of pathogens to cause more severe illness, and diminishing human capacity to cope with pathogens, such as dengue, hepatitis, pneumonia, malaria, and zika.
Read More
Annual Incidence of COVID-19 Unexpectedly Lower Among People Experiencing Homelessness
August 24th 2022Survey data indicates that people experiencing homelessness had a lower annual incidence of COVID-19 despite having a higher burden of infectious diseases, suggesting opportunities for better integration of homelessness status in infectious disease reporting.
Read More
Phase 3 Trial Investigating Onivyde for Small Cell Lung Cancer Fails to Meet Primary End Point
August 23rd 2022Irinotecan liposomal injection (Onivyde) used as second-line therapy for patients with small cell lung cancer did not meet the primary end point of overall survival compared to topotecan.
Read More
FDA Approves Zynteglo for Patients with Beta-thalassemia Requiring Regular Blood Transfusions
August 17th 2022Zynteglo was approved for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions after safety and efficacy were demonstrated in clinical trials.
Read More
Response to Psychedelic Drugs May Be Determined by Genetic Variations in Serotonin Receptor
August 8th 2022Genetic variations in the 5-hydroxytryptamine serotonin receptor uniquely impacted the receptor’s response to psychedelic drugs, including LSD and psilocin, possibly explaining why patients have varied success with psychedelic treatment for psychiatric conditions.
Read More
Overdose Deaths Increased in Wave 4 of the Opioid Crisis, Coinciding with the COVID-19 Pandemic
August 4th 2022The suggested wave 4 of the opioid crisis saw high opioid-involved overdose death rates in urban counties and high acceleration of overdose deaths in rural counties, indicating that the opioid crisis worsened during the COVID-19 pandemic.
Read More